Search
for

    Sort by

    Research 28

    1. 842Combination therapy with rofecoxib and finasteride in the treatment of men with lower urinary tract symptoms (LUTS) European Urology Supplements · 2005
    2. Chronic prostatitis and chronic pelvic pain in men: aetiology, diagnosis and management<sup>1</sup> Journal of the European Academy of Dermatology and Venereology · 2002 · 35 citations
    3. Diphlorethohydroxycarmalol, Isolated from Ishige okamurae, Increases Prostaglandin E<sub>2</sub>through the Expression of Cyclooxygenase-1 and -2 in HaCaT Human Keratinocytes Biomolecules & therapeutics · 2012 · 9 citations
    4. Drug related lipid metabolism abnormalities: a real-world pharmacovigilance exploratory analysis based on U.S. FDA adverse event reporting system (FAERS) Nutrición Hospitalaria · 2026
    5. Contemporary drug synthesis Choice Reviews Online · 2004 · 77 citations
    6. 0557 Possible Contributory and Protective Factors in Medication Associated Obstructive Sleep Apnea (OSA): Results from the US Food and Drug Administration (FDA) Adverse Events Reporting System (FAERS) Sleep · 2020
    7. Specialization and the Physician Workforce JAMA · 2000 · 27 citations
    8. New insights into the functions of Cox-2 in skin and esophageal malignancies Experimental & Molecular Medicine · 2020 · 54 citations
    9. Spontaneous cutaneous adverse drug reaction reports—An analysis of a 10‐year dataset in Singapore Pharmacology Research & Perspectives · 2019 · 13 citations
    10. Cutaneous Drug Eruptions Associated with the Use of Biologies and Cutaneous Drug Eruptions Mimicking Specific Skin Diseases Chemical Immunology · 2012 · 4 citations
    11. Cutaneous drug reactions Elsevier eBooks · 2010 · 1 citations
    12. WARFARIN 2010
    13. Cutaneous and Mucosal Lichen Planus: A Comprehensive Review of Clinical Subtypes, Risk Factors, Diagnosis, and Prognosis The Scientific World Journal · 2014 · 291 citations
    14. Peroxisome proliferator-activated receptors (PPARs) and PPAR agonists: the ‘future’ in dermatology therapeutics? Archives of dermatological research · 2015 · 60 citations
    15. Chemoprevention – History and general principles Best Practice & Research Clinical Gastroenterology · 2011 · 56 citations
    16. Treatment of chronic prostatitis/chronic pelvic pain syndrome International Journal of Antimicrobial Agents · 2008 · 50 citations
    17. Development of Provesicular Nanodelivery System of Curcumin as a Safe and Effective Antiviral Agent: Statistical Optimization, In Vitro Characterization, and Antiviral Effectiveness Molecules · 2020 · 37 citations
    18. Index of the human papillomavirus (HPV) vaccine industry clinical study programmes and non-industry funded studies: a necessary basis to address reporting bias in a systematic review Systematic Reviews · 2018 · 24 citations
    19. Clinical Management of Prostate Cancer in High-Risk Genetic Mutation Carriers Cancers · 2022 · 10 citations
    20. Finasteride Enhances the Generation of Human Myeloid-Derived Suppressor Cells by Up-Regulating the COX2/PGE2 Pathway PLOS ONE · 2016 · 10 citations
    21. Internet pharmacy: a web of mistrust? British Journal of Clinical Pharmacology · 2008 · 7 citations
    22. Prostaglandins: Key players in immunomodulation of the nervous system Neural Regeneration Research · 2025 · 3 citations
    23. ENZYMES British journal of pharmacology · 2011 · 1 citations
    24. Topical delivery of meropenem via spanlastic carbopol gel: in-vitro studies and in-vivo application in pressure ulcers Frontiers in Pharmacology · 2025
    25. Risk assessment of the top 60 drugs for drug-related sexual dysfunction: a disproportion analysis from the Food and Drug Administration adverse event reporting system The Journal of Sexual Medicine · 2025
    26. Anti-inflammatory Effects in LPS-treated RAW 264.7 Cells and the Influences on Drug Metabolizing Enzyme Activities by the Traditional Herbal Formulas, Yongdamsagan-Tang and Paljung-san Daehanhanuihakoeji · 2021
    27. Enzymes British Journal of Pharmacology · 2008
    28. ZALCITABINE 2004